Yi Chen

4.7k total citations · 1 hit paper
126 papers, 3.2k citations indexed

About

Yi Chen is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yi Chen has authored 126 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 40 papers in Oncology and 16 papers in Organic Chemistry. Recurrent topics in Yi Chen's work include Histone Deacetylase Inhibitors Research (18 papers), Cancer therapeutics and mechanisms (17 papers) and Epigenetics and DNA Methylation (12 papers). Yi Chen is often cited by papers focused on Histone Deacetylase Inhibitors Research (18 papers), Cancer therapeutics and mechanisms (17 papers) and Epigenetics and DNA Methylation (12 papers). Yi Chen collaborates with scholars based in China, United States and United Kingdom. Yi Chen's co-authors include Jian Ding, Jian Ding, Meiyu Geng, Yu Lei, Wei Lü, Yanyan Shen, Linjiang Tong, Ze‐Hong Miao, Chunhao Yang and Jing Ai and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yi Chen

119 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021

2025 18 citations Yi Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Chen China	31	1.9k	846	646	368	349	126	3.2k
Lisa Polin United States	32	1.6k 0.8×	563 0.7×	583 0.9×	218 0.6×	363 1.0×	102	3.0k
Liguang Lou China	36	1.9k 1.0×	1.5k 1.8×	697 1.1×	613 1.7×	307 0.9×	135	4.0k
Sumit Sahni Australia	35	1.9k 1.0×	1.1k 1.3×	310 0.5×	331 0.9×	409 1.2×	90	3.6k
Sylvie M. Guichard United Kingdom	33	2.3k 1.2×	1.6k 1.8×	555 0.9×	319 0.9×	445 1.3×	96	4.0k
Chryso Kanthou United Kingdom	29	1.7k 0.9×	614 0.7×	715 1.1×	262 0.7×	698 2.0×	61	3.4k
G. Ekin Atilla‐Gokcumen United States	31	1.3k 0.7×	588 0.7×	527 0.8×	153 0.4×	206 0.6×	75	2.6k
Jeff B. Smaill New Zealand	30	1.9k 1.0×	1.0k 1.2×	1.0k 1.6×	542 1.5×	392 1.1×	95	3.4k
Dimitrios T. Trafalis Greece	20	957 0.5×	792 0.9×	300 0.5×	245 0.7×	303 0.9×	113	2.2k
Yumin Hu China	33	2.4k 1.3×	630 0.7×	560 0.9×	295 0.8×	1.2k 3.4×	76	3.8k
Karuppaiyah Selvendiran United States	35	1.8k 1.0×	687 0.8×	255 0.4×	201 0.5×	854 2.4×	67	3.1k

Countries citing papers authored by Yi Chen

Since Specialization

Citations

This map shows the geographic impact of Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chen more than expected).

Fields of papers citing papers by Yi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chen. The network helps show where Yi Chen may publish in the future.

Co-authorship network of co-authors of Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Chen. A scholar is included among the top collaborators of Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Chen. Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jianju, Yi Chen, Xia Liang, et al.. (2025). Supporting cells orchestrate noise-induced hearing loss via a Gasdermin D-dependent signaling loop with hair cells. Nature Communications. 16(1). 11181–11181.

Lyu, Xilin, Xiancheng Wang, Yuhan Lu, et al.. (2025). Synthesis of an RBM39 Degrader That Downregulates CEP192 and Induces Disorganized Spindle Structures. Journal of Medicinal Chemistry. 68(7). 7807–7826.

Chen, Yi, et al.. (2024). Insight into the regulation mechanism of light spectra on astaxanthin biosynthesis in mixotrophic Chromochloris zofingiensis. Algal Research. 82. 103690–103690. 2 indexed citations

Wang, Rui, Fei Mi, Yi Chen, et al.. (2024). Role Prompting Guided Domain Adaptation with General Capability Preserve for Large Language Models. 2243–2255. 3 indexed citations

Liu, Hongyan, et al.. (2024). miR-22 negatively regulating NOD-like receptor protein 3 gene in the proliferation, invasion, and migration of malignant melanoma cells. Advances in Dermatology and Allergology. 41(3). 284–291.

Zhang, Zhuo, Qianqian Shen, Yiyi Ji, et al.. (2024). Structural Optimization of Isoquinoline Derivatives from Lycobetaine and Their Inhibitory Activity against Neuroendocrine Prostate Cancer Cells. Molecules. 29(18). 4503–4503.

Tao, Fulu, et al.. (2024). Climate change reduces agricultural total factor productivity in major agricultural production areas of China even with continuously increasing agricultural inputs. Agricultural and Forest Meteorology. 349. 109953–109953. 13 indexed citations

Zhang, Wei, Lei Bai, Wentao Xu, et al.. (2024). Sirt6 Mono‐ADP‐Ribosylates YY1 to Promote Dystrophin Expression for Neuromuscular Transmission. Advanced Science. 11(44). e2406390–e2406390. 4 indexed citations

Song, Peiran, Gege Huang, Zilan Song, et al.. (2024). Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas. Acta Pharmacologica Sinica. 45(10). 2163–2173. 2 indexed citations

10.

Xia, Peng, Yinchun Ji, Yang Dai, et al.. (2021). The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation. Molecular Cancer Therapeutics. 20(11). 2198–2206. 9 indexed citations

11.

Wang, Xinyi, Jing Ai, Hongyan Liu, et al.. (2018). The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. Molecular Cancer Therapeutics. 18(3). 667–679. 11 indexed citations

12.

Lu, Xiaoyun, Tao Zhang, Sujie Zhu, et al.. (2018). Discovery of JND3229 as a New EGFR^C797S Mutant Inhibitor with In Vivo Monodrug Efficacy. ACS Medicinal Chemistry Letters. 9(11). 1123–1127. 53 indexed citations

13.

Ai, Jing, Yi Chen, Peng Xia, et al.. (2017). Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. Molecular Cancer Therapeutics. 17(4). 751–762. 26 indexed citations

14.

Liu, Hongyan, Jing Ai, Aijun Shen, et al.. (2016). c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors. Clinical Cancer Research. 23(4). 974–984. 28 indexed citations

15.

Shen, Aijun, Lu Wang, Min Huang, et al.. (2015). c-Myc Alterations Confer Therapeutic Response and Acquired Resistance to c-Met Inhibitors in MET-Addicted Cancers. Cancer Research. 75(21). 4548–4559. 37 indexed citations

16.

Wang, Wei, Ying-Qing Wang, Tao Meng, et al.. (2014). MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189. Molecular Cancer Therapeutics. 13(6). 1480–1491. 29 indexed citations

17.

Liu, Zhiqing, Jing Ai, Peng Xia, et al.. (2014). Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities. ACS Medicinal Chemistry Letters. 5(4). 304–308. 27 indexed citations

18.

Xie, Hua, Linjiang Tong, Yong Jiang, et al.. (2011). AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo. PLoS ONE. 6(7). e21487–e21487. 43 indexed citations

19.

Chen, Yi, Mercè Jordà, Ana M. González-Angulo, et al.. (2009). Combined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant Tumors. Clinical Cancer Research. 15(10). 3396–3405. 58 indexed citations

20.

Zhang, Xiongwen, Yi Chen, Hongwu Shen, et al.. (2005). Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin. Bioorganic & Medicinal Chemistry Letters. 15(8). 2003–2006. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact